March 21, 2017 / 11:10 AM / 10 months ago

BRIEF-Asterias Biotherapeutics trial results continue to indicate positive safety profile for AST-OPC1

March 21 (Reuters) - Asterias Biotherapeutics Inc:

* Asterias Biotherapeutics Inc - trial results to date continue to indicate a positive safety profile for AST-OPC1

* Asterias Biotherapeutics Inc - there have been no serious adverse events related to AST-OPC1 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below